Kalydeco is a prescription drug used in the treatment of cystic fibrosis. The medication should only be used in patients who are at least 6 years and above with a certain gene mutation related to cystic fibrosis. Kalydeco belongs to the cystic fibrosis transmembrane conductance regulator (CFTR) class of drugs, and it works by improving the protein function in the human body. This medication helps the protein reduce thick mucus buildup in the lungs to improve other symptoms related to cystic fibrosis.
Drug Name: Kalydeco
Generic name: Ivacaftor